Related Experiment Video
Updated: May 17, 2026
11:39
Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
Published on: June 9, 2019
Targeting cancer metabolism
Beverly A Teicher1, W Marston Linehan, Lee J Helman
1Molecular Pharmacology Branch, Developmental Therapeutics Program, National Cancer Institute, Bethesda, Maryland, USA. Beverly.Teicher@nih.gov
Summary
Cancer cells reprogram metabolism, utilizing pathways like aerobic glycolysis for growth. Mutations in key metabolic enzymes (IDH1/2, SDH, FH, PKM2) offer new therapeutic targets for cancer treatment.
Area of Science:
- Oncology
- Biochemistry
- Metabolic pathways
Background:
- Oncogenes significantly impact cancer cell metabolism.
- Otto Warburg noted aerobic glycolysis in cancer cells.
- Aerobic glycolysis and nutrient uptake fuel cancer proliferation.
Purpose of the Study:
- To explore the role of metabolic enzyme alterations in cancer.
- To highlight potential therapeutic strategies targeting cancer metabolism.
Main Methods:
- Review of scientific literature on cancer metabolism and oncogenes.
- Analysis of mutations in key metabolic enzymes (IDH1/2, SDH, FH, PKM2).
Main Results:
- Mutations in IDH1/2, SDH, FH, and PKM2 are linked to various cancers.
- These mutations create specific metabolic environments, such as pseudohypoxia.
- Oncogenic metabolic lesions represent potential targets for novel cancer therapies.
Conclusions:
- Altered cancer metabolism, driven by oncogenes and specific enzyme mutations, is a critical area for therapeutic development.
- Targeting these metabolic vulnerabilities offers a promising avenue for new anticancer drugs.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.